95608-6SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by NAA with non-probe detectionActive
Term Description
Qualitative results for the detection of SARS coronavirus 2 (SARS-CoV-2) in respiratory specimens by nucleic acid amplification with non-probe based detection, such as melt curve analysis or MALDI-TOF mass spectrometry. Results may be based on multiple assays to determine the presence of the virus in a specimen. Testing is performed for the diagnosis of Coronavirus Disease 2019 (COVID-19).
Source: Regenstrief LOINC
Part Description
LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility.[PMID:31953166] Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.
The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus.
Source: LOINC
Fully-Specified Name
- Component
- SARS coronavirus 2 RNA
- Property
- PrThr
- Time
- Pt
- System
- Respiratory
- Scale
- Ord
- Method
- Non-probe.amp.tar
Additional Names
- Short Name
- SARS-CoV-2 RNA Resp Ql NAA+non-probe
- Display Name
- SARS-CoV-2 (COVID-19) RNA NAA+non-probe Ql (Resp)
- Consumer Name Alpha
- SARS-CoV-2 (COVID-19), Respiratory
Example Answer List LL5508-8
Source: Centers for Disease Control and Prevention
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Detected | LA11882-0 | ||
| Not detected | LA11883-8 | ||
| Inconclusive Copyright http://snomed.info/sct ID:419984006 Inconclusive (qualifier value) | LA9663-1 | ||
| Invalid Copyright http://snomed.info/sct ID:455371000124106 Invalid result (qualifier value) | LA15841-2 |
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.69
- Last Updated
- Version 2.69
- Order vs. Observation
- Both
Reference Information
| Type | Source | Reference |
|---|---|---|
| Webcontent | Lab Tests Online®Copyright Copyright © 2021 Lab Tests Online. All rights reserved. | Coronavirus (COVID-19) Testing |
Member of these Groups
| LG50983-2 | SARS coronavirus 2 RNA| |
| LG51017-8 | SARSCoV2 detection |
| LG51019-4 | SARSCoV2 molecular detection |
Language Variants Get Info
- zh-CNChinese (China)
- SARS 冠状病毒 2 RNA:
存在情况或阈值: 时间点: 呼吸道: 序数型: 非探针法.基因扩增.靶向 - fr-CAFrench (Canada)
- coronavirus 2 du SRAS , ARN:
Présence-Seuil: Temps ponctuel: Respiratoire: Ordinal: Non-sonde.amplification de cible - fr-FRFrench (France)
- Coronavirus SARS-CoV-2 ARN:
Présence/Seuil: Ponctuel: Respiratoire: Qualitatif: Non-PCR amplification de cible - de-DEGerman (Germany)
- SARS-Coronavirus 2 RNA:
Nachweis oder Schwellenwert: Zeitpunkt: Respirationstrakt: Ordinal: Zielfragmentamplifikation mit Detektion ohne Sonde - it-ITItalian (Italy)
- SARS coronavirus 2 RNA:
PrThr: Pt: Respiratorio: Ord: Non-sonda.amp.tar - es-MXSpanish (Mexico)
- ARN del coronavirus 2 del SARS:
Presencia o umbral: Punto temporal: Espécimen respiratorio: Ordinal: Amplificación de ácidos nucleicos con detección sin sonda - es-ESSpanish (Spain)
- Panel del SARS-CoV-2 (COVID-19) RNA:
PrThr: Punto temporal: Respiratorio: Ord: Amplificación del objetivo no basado en sonda
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=95608-6
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright